ERBB2 and breast cancer: This goes in line with a previous retrospective analysis elaborated by Valentina et al. who showed that tumors with moderate HER2 expression present an unfavorable prognosis in Luminal A, Luminal B/HER2 negative, and triple negative BC [27].